The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5,675.00
Bid: 5,665.00
Ask: 5,675.00
Change: -35.00 (-0.61%)
Spread: 10.00 (0.177%)
Open: 5,730.00
High: 5,735.00
Low: 5,650.00
Prev. Close: 5,710.00
DCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

12 Jul 2019 07:00

RNS Number : 3003F
DCC PLC
12 July 2019
 

 

 

12 July 2019

 

DCC plc

 

Interim Management Statement

 

Good Growth in First Quarter Operating Profit and Guidance for the Year Reiterated

 

DCC plc, the leading international sales, marketing and support services group, is issuing this Interim Management Statement in advance of the Company's AGM to be held in Dublin at 11.00 am today.

 

First quarter ended 30 June 2019

DCC traded in line with expectations and delivered good growth in Group operating profit for the first quarter ended 30 June 2019, driven by acquisitions completed in the prior year.

 

Year ending 31 March 2020

DCC's profits are significantly weighted towards the second half of its financial year. At what is still a very early stage in the financial year, the Group reiterates its belief that the year ending 31 March 2020 will be another year of profit growth and development.

 

Development activity

DCC Technology recently completed the acquisitions of Comm-Tec in Germany and Amacom in the Netherlands, following receipt of customary regulatory approvals. Both Comm-Tec and Amacom will significantly enhance DCC Technology's service offering in Continental Europe and will strengthen its relationships with suppliers and customers in the region.

 

DCC Retail & Oil also recently finalised the creation of a new branded aviation fuels marketing and distribution business in Denmark with Shell Aviation, which involved Shell Aviation purchasing an interest in DCC's existing Danish aviation fuels business.

 

Further detail regarding each of the above transactions is included in DCC's Development Update announcement of 14 May 2019.

 

DCC has grown substantially in recent years and now has significant operations across 18 countries, with market-leading positions in each of its LPG, Retail & Oil, Technology and Healthcare divisions. DCC's ambition and capacity for further development, together with the Group's leading market positions and increased geographic reach, provide substantial opportunity for the continued growth and development of the business.

 

Disposal

DCC Vital recently entered into an agreement to dispose of its UK generic pharma activities and related manufacturing facility in Ireland (Kent Pharma and Athlone Laboratories), subject to regulatory and other consents. The disposal will sharpen the strategic focus of DCC Vital, allowing it to concentrate on those areas where it has market leading positions and sustainable competitive advantage, in particular in the sales, marketing and distribution of medical products in Britain and Ireland. DCC Vital will also continue to develop its pharma activities in Ireland which encompass a market leadership position in the procurement and sales of Exempt Medicinal Products and agency distribution into the hospital and retail pharmacy segments.

 

 

Forthcoming events

DCC expects to announce its interim results for the six months ending 30 September 2019 on Tuesday 12 November 2019.

 

For reference:

Donal Murphy, Chief Executive

Fergal O'Dwyer, Chief Financial Officer

Kevin Lucey, Head of Capital Markets

 

Telephone: +353 1 2799 400

Email: investorrelations@dcc.ie

Web: www.dcc.ie

 

Powerscourt (Media)

Lisa Kavanagh / Victoria Palmer-Moore

Telephone: +44 20 7250 1446

Email: DCC@powerscourtgroup.com

 

 

 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth. It operates through four divisions: LPG, Retail & Oil, Technology and Healthcare.

 

DCC is an ambitious and entrepreneurial business operating in 18 countries, supplying products and services used by millions of people every day. Building strong routes to market, driving for results, focusing on cash conversion and generating superior sustainable returns on capital employed enable the Group to reinvest in its business, creating value for its stakeholders.

 

Headquartered in Dublin, employing approximately 12,700 people, DCC's four divisions are:

· DCC LPG - a leading LPG sales and marketing business with operations in Europe, the US and Asia and a developing business in the retailing of natural gas and electricity;

· DCC Retail & Oil - a leader in the sales, marketing and retailing of transport and commercial fuels, heating oils and related products and services in Europe;

· DCC Technology - a leading route-to-market and supply chain partner for global technology brands and customers; and

· DCC Healthcare - a leading healthcare business, providing products and services to healthcare providers and health and beauty brand owners.

 

DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2019, DCC generated revenue of £15.2 billion and operating profit of £460.5 million.

 

DCC has an excellent record, delivering compound annual growth of 14.6% in operating profit and generating an average return on capital employed of approximately 19% over 25 years as a public company.

 

Forward-looking statements

This announcement contains some forward-looking statements that represent DCC's expectations for its business, based on current expectations about future events, which by their nature involve risk and uncertainty. DCC believes that its expectations and assumptions with respect to these forward-looking statements are reasonable, however because they involve risk and uncertainty as to future circumstances, which are in many cases beyond DCC's control, actual results or performance may differ materially from those expressed in or implied by such forward-looking statements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTQFLFFKDFLBBZ
Date   Source Headline
30th May 20134:17 pmRNSTreasury Shares
24th May 20139:58 amRNSHolding(s) in Company
22nd May 201312:50 pmRNSTreasury Shares
20th May 20131:02 pmRNSTreasury Shares
14th May 20137:00 amRNSPreliminary Results for year ended 31 March 2013
7th May 20133:18 pmRNSHolding(s) in Company
7th May 20133:06 pmRNSHolding(s) in Company
7th May 20132:50 pmRNSHolding(s) in Company
7th May 20137:00 amRNSMSM - Cancellation Notice
17th Apr 20133:51 pmRNSHolding(s) in Company
12th Apr 20135:10 pmRNSHolding in Company TR-1
11th Apr 20135:25 pmRNSHolding in Company TR-1
4th Apr 20134:24 pmRNSHolding in Company TR-1
4th Apr 20134:21 pmRNSHolding in Company TR-1
22nd Mar 20134:40 pmRNSHolding in Company
19th Mar 20133:05 pmRNSHolding in Company TR-1
15th Mar 20133:55 pmRNSHolding in Company TR-1
6th Mar 20135:45 pmRNSHolding in Company TR-1
1st Mar 20134:00 pmRNSHolding in Company TR-1
28th Feb 20133:36 pmRNSTotal Voting Rights
27th Feb 20137:00 amRNSDCC completes acquisition
26th Feb 20134:41 pmRNSTreasury Shares
26th Feb 20137:00 amRNSChange in listing arrangements
18th Feb 20134:08 pmRNSTreasury Shares
8th Feb 20135:27 pmRNSTreasury Shares
8th Feb 20138:32 amRNSDirector Declaration
6th Feb 201312:16 pmRNSTreasury Shares
6th Feb 20137:00 amRNSInterim Management Statement
5th Feb 20139:38 amRNSHolding in Company TR-1
23rd Jan 20133:02 pmRNSMerger Update
4th Jan 201310:38 amRNSHolding in Company - TR1
20th Dec 201210:24 amRNSDCC Healthcare Acquisition of Kent Pharmaceuticals
11th Dec 20121:06 pmRNSHolding(s) in Company
10th Dec 20127:00 amRNSDCC completes acquisition
30th Nov 20122:54 pmRNSVoting Rights and Capital
27th Nov 20124:09 pmRNSHolding in Company
27th Nov 20124:06 pmRNSHolding in Company
20th Nov 20122:44 pmRNSTreasury Shares
14th Nov 20125:21 pmRNSDirector/PDMR Shareholding
14th Nov 20123:36 pmRNSTreasury Shares
12th Nov 20124:57 pmRNSDirector/PDMR Shareholding
6th Nov 20127:00 amRNSInterim Results Six Months ended 30 September 2012
5th Nov 20124:03 pmRNSDCC plc Board Retirement
1st Nov 20127:00 amRNSDCC completes the acquisition of Benegas
31st Oct 20124:00 pmRNSMerger Update
24th Oct 201211:10 amRNSHolding in Company - TR 1
19th Oct 201211:00 amRNSMerger Update
1st Oct 20127:00 amRNSDCC completes acquisition
28th Sep 20121:00 pmRNSTotal Voting Rights
21st Sep 20128:00 amRNSDCC to expand LPG business into the Benlux region

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.